Genmark Diagnostics Inc – NASDAQ:GNMK

Genmark Diagnostics stock price today

$24.05
+0.01
+0.04%
Financial Health
0
1
2
3
4
5
6
7
8
9

Genmark Diagnostics stock price monthly change

+0.17%
month

Genmark Diagnostics stock price quarterly change

+55.90%
quarter

Genmark Diagnostics stock price yearly change

+169.81%
year

Genmark Diagnostics key metrics

Market Cap
 1.76B
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.28
Revenue
 171.55M
EBITDA
 -3.59M
Income
 -18.64M
Revenue Q/Q
 84.14%
Revenue Y/Y
 94.90%
Profit margin
 -10.87%
Oper. margin
 -6.44%
Gross margin
 39.61%
EBIT margin
 -6.44%
EBITDA margin
 -2.09%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Genmark Diagnostics stock price history

Genmark Diagnostics stock forecast

Genmark Diagnostics financial statements

Profit Margin

Genmark Diagnostics Inc (NASDAQ:GNMK): Profit margin
Mar 2020 38.74M -7.00M -18.09%
Jun 2020 40.08M -4.68M -11.68%
Sep 2020 42.64M -3.22M -7.57%
Dec 2020 50.08M -3.72M -7.44%
GNMK income statement history

Quarterly Earnings

Genmark Diagnostics Inc (NASDAQ:GNMK): Earnings per share (EPS)
2020-08-04 -0.09 -0.07
2020-10-28 -0.06 -0.05
2021-02-25 -0.01 -0.05
GNMK earnings history

Debt to Assets

Genmark Diagnostics Inc (NASDAQ:GNMK): Debt to assets
Mar 2020 111592000 98.58M 88.35%
Jun 2020 195013000 104.83M 53.76%
Sep 2020 214590000 120.63M 56.22%
Dec 2020 223534000 129.33M 57.86%
GNMK balance sheet history

Cash Flow

Genmark Diagnostics Inc (NASDAQ:GNMK): Cash Flow
Mar 2020 -7.60M -12.66M 2.14M
Jun 2020 7.99M -30.31M 79.38M
Sep 2020 6.28M -35.37M 4.51M
Dec 2020 -537K -18.15M 1.53M
GNMK cash flow history

Genmark Diagnostics other data

Genmark Diagnostics
Insider Trading

Genmark Diagnostics Inc (NASDAQ:GNMK): Insider trades (number of shares)
Period Buy Sel
Apr 2020 0 13848
May 2020 0 34928
Jun 2020 0 4780
Jul 2020 0 6171
Aug 2020 0 259871
Sep 2020 0 52974
Oct 2020 0 73571
Nov 2020 0 90330
Dec 2020 0 17016
Jan 2021 0 328462
Feb 2021 0 63496
Mar 2021 0 3401
Transaction Date Insider Security Shares Price per share Total value Source
Option
GLEESON MICHAEL officer: SVP, Corp. Accounts
 Common Stock 27,667 $3.63 $100,431
Option
GLEESON MICHAEL officer: SVP, Corp. Accounts
 Stock Option (Right to Buy) 27,667 $12.12 $335,324
Sale
JENSEN TYLER officer: SVP, Engineering and T..
 Common Stock 500 N/A N/A
Sale
SHAW CHRISTINE officer: VP, Assay Development
 Common Stock 274 N/A N/A
Sale
JENSEN TYLER officer: SVP, Engineering and T..
 Common Stock 500 N/A N/A
Sale
MADERAZO ALAN BAER officer: VP, Qual, Reg, & Clin ..
 Common Stock 2,127 N/A N/A
Sale
SHAW CHRISTINE officer: VP, Assay Development
 Common Stock 3,151 $17.03 $53,662
Sale
WINKLER SARAH HOLLIS officer: VP, Human Resources
 Common Stock 11,181 $17.01 $190,189
Sale
HARKINS MICHAEL JOHN officer: SVP, Sales
 Common Stock 12,381 $17.03 $210,848
Sale
GLEESON MICHAEL officer: SVP, Corp. Accounts
 Common Stock 17,750 $17.01 $301,928
GNMK insider trading transactions

Genmark Diagnostics
Patents

Patent
Application
Filling date: 19 Aug 2020 Issue date: 24 Feb 2022
Grant
Filling date: 28 Apr 2020 Issue date: 26 Oct 2021
Grant
Filling date: 9 Mar 2018 Issue date: 26 Oct 2021
Application
Filling date: 28 Apr 2021 Issue date: 12 Aug 2021
Application
Filling date: 26 Jan 2021 Issue date: 17 Jun 2021
Application
Filling date: 27 Jan 2021 Issue date: 10 Jun 2021
Application
Filling date: 8 Jan 2021 Issue date: 20 May 2021
Grant
Filling date: 23 Jul 2018 Issue date: 16 Mar 2021
Application
Filling date: 11 Nov 2020 Issue date: 4 Mar 2021
Grant
Filling date: 1 Jun 2018 Issue date: 2 Mar 2021
GNMK patents

Genmark Diagnostics
Earnings Call Transcripts

Quarter Transcript
Q4 2020 25 Feb 2021 Q4 2020 Earnings Call Transcript
Q2 2020 5 Aug 2020 Q2 2020 Earnings Call Transcript
Q1 2020 5 May 2020 Q1 2020 Earnings Call Transcript
Q4 2019 3 Mar 2020 Q4 2019 Earnings Call Transcript
GNMK earnings call transcripts

Frequently Asked Questions (FAQ)

  • What's the price of Genmark Diagnostics stock today?

    One share of Genmark Diagnostics stock can currently be purchased for approximately $24.05.

  • When is Genmark Diagnostics's next earnings date?

    Unfortunately, Genmark Diagnostics's (GNMK) next earnings date is currently unknown.

  • Does Genmark Diagnostics pay dividends?

    No, Genmark Diagnostics does not pay dividends.

  • How much money does Genmark Diagnostics make?

    Genmark Diagnostics has a market capitalization of 1.76B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 94.9% to 171.55M US dollars. Genmark Diagnostics made a loss 18.64M US dollars in net income (profit) last year or -$0.05 on an earnings per share basis.

  • What is Genmark Diagnostics's stock symbol?

    Genmark Diagnostics Inc is traded on the NASDAQ under the ticker symbol "GNMK".

  • What is Genmark Diagnostics's primary industry?

    Company operates in the Healthcare sector and Medical Devices industry.

  • How do i buy shares of Genmark Diagnostics?

    Shares of Genmark Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Genmark Diagnostics have?

    Genmark Diagnostics Inc employs 437 workers.

  • When Genmark Diagnostics went public?

    Genmark Diagnostics Inc is publicly traded company for more then 15 years since IPO on 2 Jun 2010.

  • What is Genmark Diagnostics's official website?

    The official website for Genmark Diagnostics is genmarkdx.com.

  • Where are Genmark Diagnostics's headquarters?

    Genmark Diagnostics is headquartered at 5964 La Place Ct, Carlsbad, CALIFORNIA.

  • How can i contact Genmark Diagnostics?

    Genmark Diagnostics's mailing address is 5964 La Place Ct, Carlsbad, CALIFORNIA and company can be reached via phone at +1 760 448 4300.

Genmark Diagnostics company profile:

Genmark Diagnostics Inc

genmarkdx.com
Exchange:

NASDAQ

Full time employees:

437

Industry:

Medical Devices

Sector:

Healthcare

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.

+1 760 448 4300
5964 La Place Ct
Carlsbad, CALIFORNIA 92008-8829

CIK: 0001487371
ISIN: US3723091043
CUSIP: 372309104